Semin Respir Crit Care Med 2002; 23(3): 239-247
DOI: 10.1055/s-2002-33032
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Respiratory Complications of Amyotrophic Lateral Sclerosis

Joshua O. Benditt
  • University of Washington Medical Center, Division of Pulmonary and Critical Care Medicine, Seattle, Washington
Further Information

Publication History

Publication Date:
02 August 2002 (online)

ABSTRACT

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with no known cure. Involvement of muscles of the respiratory system, the inspiratory, expiratory, and upper airway muscles, is the major cause of morbidity and mortality. Dyspnea, swallowing difficulties, sialorrhea, and impaired cough are all symptoms that can be palliated with pharmacological and nonpharmacological methods. Noninvasive positive pressure ventilation (NPPV) in particular is a technique to assist ventilation that not only relieves dyspnea and ameliorates respiratory failure but may also extend the lives of patients with this disease. It should be offered to all ALS patients with a forced vital capacity of less than 50%.

REFERENCES

  • 1 Milonas I. Amyotrophic lateral sclerosis: an introduction.  J Neurol . 1998;  245 S1-3
  • 2 Rowland L P. Amyotrophic lateral sclerosis.  Curr Opin Neurol . 1994;  7 310-315
  • 3 Rowland L P. Amyotrophic lateral sclerosis: theories and therapies [editorial; comment].  Ann Neurol . 1994;  35 129-130
  • 4 Rowland L P. Amyotrophic lateral sclerosis: human challenge for neuroscience.  Proc Natl Acad Sci U S A . 1995;  92 1251-1253
  • 5 Rowland L P. Controversies about amyotrophic lateral sclerosis.  Neurologia . 1996;  11(suppl)5 S72-S74
  • 6 Boukaftane Y, Khoris J, Moulard B. Identification of six novel SOD1 gene mutations in familial amyotrophic lateral sclerosis.  Can J Neurol Sci . 1998;  25 192-196
  • 7 Brown D W. Amyotrophic lateral sclerosis: hypothetical pathogenesis.  Med Hypotheses . 1994;  42 393-394
  • 8 Tidwell J. Pulmonary management of the ALS patient.  J Neurosci Nurs . 1993;  25 337-342
  • 9 Miller R G, Rosenberg J A, Gelinas D F. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review).  Muscle Nerve . 1999;  22 1104-1118
  • 10 Kasarskis E J, Neville H E. Management of ALS: nutritional care.  Neurology . 1996;  47 S118-120
  • 11 Gryfe P, Kurtz I, Gutmann M, Laiken G. Freedom through a single switch: coping and communicating with artificial ventilation.  J Neurol Sci . 1996;  139 132-133
  • 12 Leith D E. Cough. In: Brain JD, Proctor D, Reid L, eds. Lung Biology in Health and Disease: Respiratory Defense Mechanisms Pt 2. New York: Marcel Dekker 1977: 545-592
  • 13 Polkey M I, Lyall R A, Green M, Nigel Leigh P, Moxham J. Expiratory muscle function in amyotrophic lateral sclerosis.  Am J Respir Crit Care Med . 1998;  158 734-741
  • 14 Bach J R. Amyotrophic lateral sclerosis: communication status and survival with ventilatory support [published erratum appears in Am J Phys Med Rehabil 1994 Jun;73(3):218].  Am J Phys Med Rehabil . 1993;  72 343-349
  • 15 Bach J R. Amyotrophic lateral sclerosis: predictors for prolongation of life by noninvasive respiratory aids.  Arch Phys Med Rehabil . 1995;  76 828-832
  • 16 Kang S W, Bach J R. Maximum insufflation capacity: vital capacity and cough flows in neuromuscular disease.  Am J Phys Med Rehabil . 2000;  79 222-227
  • 17 Kang S W, Bach J R. Maximum insufflation capacity.  Chest . 2000;  118 61-65
  • 18 Fromm G B, Wisdom P J, Block A J. Amyotrophic lateral sclerosis presenting with respiratory failure: diaphragmatic paralysis and dependence on mechanical ventilation in two patients.  Chest . 1977;  71 612-614
  • 19 de Carvalho M, Matias T, Coelho F, Evangelista T, Pinto A, Luis M L. Motor neuron disease presenting with respiratory failure.  J Neurol Sci . 1996;  139 117-122
  • 20 Carre P C, Didier A P, Tiberge Y M, Arbus L J, Leophonte P J. Amyotrophic lateral sclerosis presenting with sleep hypopnea syndrome.  Chest . 1988;  93 1309-1312
  • 21 Barthlen G M, Lange D J. Unexpectedly severe sleep and respiratory pathology in patients with amyotrophic lateral sclerosis.  Eur J Neurol . 2000;  7 299-302
  • 22 Fallat R J, Norris F H, Holden D, Kandal K, Roggero P C. Respiratory monitoring and treatment: objective treatments using noninvasive measurements.  Adv Exp Med Biol . 1987;  209 191-200
  • 23 Black L F, Hyatt R E. Maximal static respiratory pressures in generalized neuromuscular disease.  Am Rev Respir Dis . 1971;  103 641-650
  • 24 Chokroverty S. Sleep and degenerative neurologic disorders.  Neurol Clin . 1996;  14 807-826
  • 25 Culebras A. Sleep and neuromuscular disorders.  Neurol Clin . 1996;  14 791-805
  • 26 David W S, Bundlie S R, Mahdavi Z. Polysomnographic studies in amyotrophic lateral sclerosis.  J Neurol Sci . 1997;  S29-35
  • 27 Ferguson K A, Strong M J, Ahmad D, George C F. Sleep-disordered breathing in amyotrophic lateral sclerosis.  Chest . 1996;  110 664-669
  • 28 Barthlen G M. Nocturnal respiratory failure as an indication of noninvasive ventilation in the patient with neuromuscular disease [see comments].  Respiration . 1997;  64 35-38
  • 29 Hetta J, Jansson I. Sleep in patients with amyotrophic lateral sclerosis.  J Neurol . 1997;  244 S7-S9
  • 30 Gay P C, Westbrook P R, Daube J R, Litchy W J, Windebank A J, Iverson R. Effects of alterations in pulmonary function and sleep variables on survival in patients with amyotrophic lateral sclerosis.  Mayo Clin Proc . 1991;  66 686-694
  • 31 Bensimon G, Lacomblez L, Meininger V, Group at ARS. A controlled trial of riluzole in amyotrophic lateal sclerosis.  N Engl J Med . 1994;  347 1425-1431
  • 32 Carter G T, Johnson E R, Bonekat H W, Lieberman J S. Laryngeal diversion in the treatment of intractable aspiration in motor neuron disease.  Arch Phys Med Rehabil . 1992;  73 680-682
  • 33 Blasco P A, Stansbury J CK. Glycopyrrolate treatment of chronic drooling.  Arch Pediatr Adolesc Med . 1996;  150 932-935
  • 34 Brodtkorb E, Wyzock-Bakowska M M, Lillevold P E, Sandvik L, Saunte C, Hestnes A. Transdermal scopolamine in drooling.  J Ment Def Res . 1988;  32 233-237
  • 35 Campo-Bruno J A, Winsberg B G, Green-Parsons A R, Abrams J P. Efficacy of benztropine therapy for drooling.  Dev Med Child Neurol . 1989;  31 309-319
  • 36 Newell A R, Orser R, Hunt M. The control of oral secretions in bulbar ALS/MND.  J Neurol Sci . 1996;  139(suppl) 43-44
  • 37 Reddihough D, Johnson H, Staples M, Hudson I, Exarchos H. Use of trihexyphenidol hydrochloride to control drooling of children with cerebral palsy.  Dev Med Child Neurol . 1990;  32 985-989
  • 38 Kasarskis E J, Scarlata D, Hill R, Fuller C, Stambler N, Cedarbaum J M. A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials.  J Neurol Sci . 1999;  169 118-125
  • 39 Mathus-Vliegen L M, Louwerse L S, Merkus M P, Tytgat G N, Vianney de Jong M J. Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis and impaired pulmonary function.  Gastrointest Endosc . 1994;  40 463-469
  • 40 Mazzini L, Corra T, Zaccala M, Mora G, Del Piano M, Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis.  J Neurol . 1995;  242 695-698
  • 41 Boitano L J, Jordan T, Benditt J O. Noninvasive ventilation allows gastrostomy tube placement in patients with advanced ALS.  Neurology . 2001;  56 413-414
  • 42 Hanayama K, Ishikawa Y, Bach J R. Amyotrophic lateral sclerosis: successful treatment of mucous plugging by mechanical insufflation-exsufflation.  Am J Phys Med Rehabil . 1997;  76 338-339
  • 43 Stambler N, Charatan M, Cedarbaum J M. Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group.  Neurology . 1998;  50 66-72
  • 44 Lyall R A, Donaldson N, Fleming T. A prospective study of quality of life in ALS patients treated with noninvasive ventilation.  Neurology . 2001;  57 153-156
  • 45 Pinto A C, Evangelista T, Carvalho M, Alves M A, Sales Luis L M. Respiratory assistance with a noninvasive ventilator (Bipap) in MND/ALS patients: survival rates in a controlled trial.  J Neurol Sci . 1995;  129 19-26
  • 46 Cazzolli P A, Oppenheimer E A. Home mechanical ventilation for amyotrophic lateral sclerosis: nasal compared to tracheostomy-intermittent positive pressure ventilation.  J Neurol Sci . 1996;  139 123-128
  • 47 Aboussouan L S, Khan S U, Meeker D P, Stelmach K, Mitsumoto H. Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis [see comments].  Ann Intern Med . 1997;  127 450-453
  • 48 Kleopas K A, Sherman M, Beal B, Romano G J, Heiman-Patterson T. Bipap improves survival and rate of pulmonary function decline in patients with ALS.  J Neurol Sci . 1999;  164 82-88
  • 49 Bradley W G, Anderswon F, Bromberg M. Current management of ALS: comparison of the ALS CARE Database and AAN Practice Parameter.  Neurology . 2001;  2001 500-504
  • 50 Oppenheimer E A. Decision-making in the respiratory care of amyotrophic lateral sclerosis: should home mechanical ventilation be used?.  Palliat Med . 1993;  7 49-64
  • 51 Gelinas D F, O'Connor P, Miller R G. Quality of life for ventilator-dependent ALS patients and their caregivers.  J Neurol Sci . 1998;  160 S134-136
  • 52 Borasio G D, Gelinas D F, Yanagisawa N. Mechanical ventilation in amyotrophic lateral sclerosis: a cross-cultural perspective.  J Neurol . 1998;  245 S7-S29
  • 53 Kristjanson L J, Nelson F, Henteleff P. Palliative care for individuals with amyotrophic lateral sclerosis.  J Palliative Care . 1987;  2 28-34
  • 54 Borasio G D, Voltz R. Palliative care in amyotrophic lateral sclerosis.  J Neurol . 1997;  244 S11-S17
  • 55 Bascom P B, Tolle S W, Cassel C K. Caring for the terminally ill.  Hosp Pract (Off Ed) . 1996;  31 75-90
  • 56 Albert S M, Murphy P L, Del Bene L M, Rowland L P. Prospective study of palliative care in ALS: choice, timing, outcomes.  J Neurol Sci . 1999;  169 108-113
  • 57 Ganzini L, Johnston W S, McFarland B H, Tolle S W, Lee M A. Attitudes of patients with amyotrophic lateral sclerosis and their care givers toward assisted suicide.  N Engl J Med . 1998;  339 967-973
    >